Literature DB >> 25436421

MicroRNA-520g induces epithelial-mesenchymal transition and promotes metastasis of hepatocellular carcinoma by targeting SMAD7.

Heping Kan1, Wenbin Guo2, Yuqi Huang3, Dingli Liu4.   

Abstract

Hepatocellular carcinoma (HCC) is the third leading cause of cancer-related death worldwide. Aberrant expression of miRNAs contributes to HCC development. Here, we observed elevated miR-520g expression in tumor samples from HCC patients with relapse and metastasis, and this high miR-520g expression was correlated with poor survival. Through gain- and loss-of-function studies, miR-520g was demonstrated to facilitate HCC cell migration, invasion and epithelial-mesenchymal transition (EMT). SMAD7 was identified as a direct target of miR-520g. Accordingly, we conclude that high miR-520g expression promotes HCC cell mobility and EMT by targeting SMAD7, and this is correlated with reduced survival in HCC patients.
Copyright © 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cancer metastasis; Epithelial–mesenchymal transition; Hepatocellular carcinoma; MicroRNA-520g; SMAD family member 7

Mesh:

Substances:

Year:  2014        PMID: 25436421     DOI: 10.1016/j.febslet.2014.11.031

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  21 in total

1.  Relationship between ADH2 Arg47His variation and hepatocellular carcinoma susceptibility: a meta analysis.

Authors:  Shuzhen Liu; Yongchun Cui; Baohong Yang; Ping Chai; Zheng Su; Qianqian Zhang; Dejie Zheng; Rui Li; Guohua Yu
Journal:  Int J Clin Exp Med       Date:  2015-06-15

2.  Tissue Factor Regulation by miR-520g in Primitive Neuronal Brain Tumor Cells: A Possible Link between Oncomirs and the Vascular Tumor Microenvironment.

Authors:  Esterina D'Asti; Annie Huang; Marcel Kool; Brian Meehan; Jennifer A Chan; Nada Jabado; Andrey Korshunov; Stefan M Pfister; Janusz Rak
Journal:  Am J Pathol       Date:  2015-12-12       Impact factor: 4.307

3.  CRCT1 regulated by microRNA-520 g inhibits proliferation and induces apoptosis in esophageal squamous cell cancer.

Authors:  Ning Wu; Yang Song; Liewen Pang; Zhiming Chen
Journal:  Tumour Biol       Date:  2015-12-30

4.  Overexpression of annexin A4 indicates poor prognosis and promotes tumor metastasis of hepatocellular carcinoma.

Authors:  Wenwei Chen; Lihong Chen; Zhixiong Cai; Dong Liang; Bixing Zhao; Yongyi Zeng; Xiaolong Liu; Jingfeng Liu
Journal:  Tumour Biol       Date:  2016-01-16

5.  MiR-186 suppresses the growth and metastasis of bladder cancer by targeting NSBP1.

Authors:  Kun Yao; Leye He; Yu Gan; Qing Zeng; Yingbo Dai; Jing Tan
Journal:  Diagn Pathol       Date:  2015-08-20       Impact factor: 2.644

6.  MicroRNA-92b promotes hepatocellular carcinoma progression by targeting Smad7 and is mediated by long non-coding RNA XIST.

Authors:  L K Zhuang; Y T Yang; X Ma; B Han; Z S Wang; Q Y Zhao; L Q Wu; Z Q Qu
Journal:  Cell Death Dis       Date:  2016-04-21       Impact factor: 8.469

7.  Loss of miR-449a in ERG-associated prostate cancer promotes the invasive phenotype by inducing SIRT1.

Authors:  Parameet Kumar; Shashwat Sharad; Gyorgy Petrovics; Ahmed Mohamed; Albert Dobi; Taduru L Sreenath; Shiv Srivastava; Roopa Biswas
Journal:  Oncotarget       Date:  2016-04-19

8.  DDR2 facilitates hepatocellular carcinoma invasion and metastasis via activating ERK signaling and stabilizing SNAIL1.

Authors:  Binhui Xie; Weihao Lin; Junming Ye; Xiaonong Wang; Bing Zhang; Shiqiu Xiong; Heping Li; Guosheng Tan
Journal:  J Exp Clin Cancer Res       Date:  2015-09-11

9.  MiR-519d facilitates the progression and metastasis of cervical cancer through direct targeting Smad7.

Authors:  Jue-Yu Zhou; Si-Rong Zheng; Jie Liu; Rong Shi; Hai-Lang Yu; Min Wei
Journal:  Cancer Cell Int       Date:  2016-03-22       Impact factor: 5.722

10.  MicroRNA-212 inhibits hepatocellular carcinoma cell proliferation and induces apoptosis by targeting FOXA1.

Authors:  Huahua Tu; Gang Wei; Qinghe Cai; Xianxiang Chen; Zequn Sun; Caitao Cheng; Linfei Zhang; Yong Feng; Huadong Zhou; Bo Zhou; Tiancai Zeng
Journal:  Onco Targets Ther       Date:  2015-08-24       Impact factor: 4.345

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.